Skip to main content
. 2021 Oct;10(10):4532–4552. doi: 10.21037/tcr-21-687

Table 3. List of common lncRNA biomarkers for esophageal cancer.

Name Expression Mechanism Biomarker potency Site of detection Detection method Reference
LINC00152 ↑ (100) Interacts with EZH2, positively regulate the expression of ZEB1, enhance the EMT of EC cells (101) (i), (iii) Whole blood (100), Animal (100,101) (a, b) RT-qPCR, Tumor formation study, (100,101)
HOTTIP Up-regulated snail1 by competitively binding miR-30b, regulate the Hottip-miR-30b-HOXA13 axis in ESCC (i), (ii), (iii) Tumor, cell line (a) RT-qPCR, Dual-luciferase reporter assay (102)
FOXD2-AS1 ↑ (103) Regulate miR-145-5p/CDK6 axis, significantly inhibit the proliferation and invasion of esophageal cancer cells (104) (i), (iii), (iv) (103,104) Tumor (a) RT-qPCR, WB (103,104)
HOTAIR ↑ (97) HOTAIR decreased WIF-1 expression, regulate HOTAIR/WIF-1 axis (105) (ii) (106,107) Tumor, serum (a) Microarray, RT-qPCR (97,105-107)
PVT1 Competitively bind miRNA- 203, regulate the expression of human recombinant LIM and SH3 protein 1 in ESCC (ii) tumor, mice (a, b) RT-qPCR, Immunohistochemical, Tumor formation study, (108)
AK001796 Regulate the MDM2/P53 signal pathway in ESCC (ii) Tumor, mice (a, b) RT-qPCR, RT-PCR, Tumor formation study, (109)
MEG3 Interact with MI R-4261, inhabit recombinant DKK2 and block Wnt/β-catenin signaling, inhibit the occurrence and development of ESCC (i), (ii) Tumor, mice (a, b) RT-qPCR, Luciferase reporter assay, WB, Tumor formation study, (110)
LncRNA-TUSC7 bound to miR-224, miR-224 specifically bound to DESC1, DESC1 inhibited chemotherapy resistance of ESCC cells via EGFR/AKT (i), (iii), (iv) Tumor (a) RT-qPCR, bioinformatics (111)

↑, represents up-regulated gene expression in tumor tissue; ↓, represents down-regulated gene expression in tumor tissue; (i), diagnostic; (ii), prognostic; (iii), therapeutic; (iv), metastasis monitoring. RT-qPCR, real-time quantitative PCR; WB, western blot; RT-PCR, reverse transcription PCR; ESCC, esophageal squamous cell cancer.